Molecular pathways in periampullary cancer: An overview
Authors:
- ApurvaAPApurva
- NimishaNINimisha
- Sundeep Singh SalujaSSSundeep Singh Saluja
- 9 September 2022
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 100, 110461
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/INF/22/SP33063/2019)
- Indian Council of Medical Research (ID-3/2/2/61/2020-NCD-2020)
This publication has 98 references indexed in Scilit:
- Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerabilityGenome Medicine, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Targeting the transforming growth factor-β signaling pathway in human cancerExpert Opinion on Investigational Drugs, 2009
- Molecular Analysis of PIK3CA, BRAF, and RAS Oncogenes in Periampullary and Ampullary Adenomas and CarcinomasJournal of Gastrointestinal Surgery, 2009
- An audit of outcomes of a series of periampullary carcinomasEuropean Journal of Surgical Oncology, 2009
- Tumors of the Ampulla of Vater: Histopathologic Classification and Predictors of SurvivalJournal of the American College of Surgeons, 2008
- CholangiocarcinomaAnnals of Surgery, 2007
- A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 2005
- Mutations of the BRAF gene in human cancerNature, 2002